Fulcrum Therapeutics Cash Flow Statement (2018-2026) | FULC

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-96.47M-50.95M-94.00M-35.44M-27.08M-192.46M-30.52M-30.65M-40.26M-43.11M-65.24M40.22M-25.68M-25.03M-29.43M-41.97M-64.99M-84.15M-49.97M-34.98M
Depreciation and Depletion (Quarter)
0.60M0.60M0.50M0.70M0.60M0.59M0.60M0.60M0.50M0.54M0.48M0.40M0.40M0.40M0.40M0.30M0.30M0.40M0.30M0.20M
Share-based Compensation (Quarter)
2.66M3.79M3.85M2.88M3.35M3.27M4.25M3.36M3.74M3.45M3.92M4.34M3.82M2.48M3.17M26.10M22.30M3.07M3.86M22.30M
Asset Writedowns and Impairment (Quarter)
5.09M
Cash from Operations (Quarter)
-16.04M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
-0.09M-0.39M-0.35M-0.29M-0.11M0.60M1.37M1.71M1.58M1.33M1.16M1.13M1.15M0.94M0.90M1.08M0.59M0.38M0.77M0.81M
Depreciation & Amortization (CF) (Quarter)
0.60M0.60M0.50M0.70M0.60M0.59M0.60M0.60M0.50M0.54M0.48M0.40M0.40M0.40M0.40M0.30M0.30M0.40M0.30M0.20M
Change in Working Capital
Change in Receivables (Quarter)
2.50M0.34M1.81M0.34M-3.40M-0.13M0.56M-0.08M-0.04M-0.54M2.33M1.32M-1.56M-1.12M-0.98M
Change in Account Payables (Quarter)
0.97M
Change in Accured Expenses (Quarter)
-1.05M
Investing Activities
Capital Expenditures (Quarter)
0.11M
Change in Acquisitions & Divestments (Quarter)
37.65M
Cash from Investing Activities (Quarter)
13.78M
Financing Activities
Other financing activities (Quarter)
Change in Capital Stock
Shares Issued (Quarter)
11.63M
Net Equity Issued and Repurchased (Quarter)
0.36M
Misc.
Cash from Financing Activities (Quarter)
0.36M
Change in Cash (Quarter)
-1.90M
Free Cash Flow (Quarter)
-16.15M
Net Cash Flow (Quarter)
-1.90M